Saudi Arabia Diabetes Devices Market Size, Share & Trends Analysis Report By Type (BGM Devices, Insulin Delivery Devices), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By End-use (Hospitals, Diagnostic Centers), And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
Saudi Arabia Diabetes Devices Market Growth & Trends
The Saudi Arabia diabetes devices market size is anticipated to reach USD 319.3 million by 2030, exhibiting a CAGR of 8.14% during the forecast period, according to a new report by Grand View Research, Inc. The major factors contributing to market growth include the increasing prevalence of diabetes in the nation, technological advancements, and growing initiatives undertaken by the government. For instance, in January 2023, Saudi Arabia signed two agreements with the goal of improving diabetes treatment and prevention. These memorandums of understanding were signed with Boehringer Ingelheim, a German pharmaceutical firm, and Novo Nordisk, a Danish healthcare company. The aims of these agreements encompass fostering collaboration within the biotech and pharmaceutical sector, advancing local manufacturing, enhancing awareness about diabetes, and establishing research centers within the Kingdom.
Diabetes devices serve as highly effective instruments in diabetes management, providing both patients and healthcare providers with streamlined methods for monitoring blood glucose levels, administering insulin, and enhancing treatment effectiveness. A critical element of these devices efficiency is their capacity to deliver precise and prompt information on glucose levels. Technological progressions in these devices are anticipated to bolster market expansion. Notably, the development of continuous glucose monitoring (CGM) systems represents a significant advancement, furnishing real-time glucose readings around the clock, and eliminating the necessity for frequent fingerstick tests.
Furthermore, companies operating in the Saudi Arabia diabetes devices industry are working to improve their product offerings by upgrading their products, leveraging important cooperative drives, as well as considering acquisitions and government approvals these efforts are aimed at expanding their customer base and gaining a larger share of the market. For instance, in August 2023, Nemaura Medical received Saudi Food and Drug Authority (SFDA) approval for its sugarBEAT sensor, a non-invasive glucose sensor.
Saudi Arabia Diabetes Devices Market Report Highlights
Saudi Arabia Diabetes Devices Market Growth & Trends
The Saudi Arabia diabetes devices market size is anticipated to reach USD 319.3 million by 2030, exhibiting a CAGR of 8.14% during the forecast period, according to a new report by Grand View Research, Inc. The major factors contributing to market growth include the increasing prevalence of diabetes in the nation, technological advancements, and growing initiatives undertaken by the government. For instance, in January 2023, Saudi Arabia signed two agreements with the goal of improving diabetes treatment and prevention. These memorandums of understanding were signed with Boehringer Ingelheim, a German pharmaceutical firm, and Novo Nordisk, a Danish healthcare company. The aims of these agreements encompass fostering collaboration within the biotech and pharmaceutical sector, advancing local manufacturing, enhancing awareness about diabetes, and establishing research centers within the Kingdom.
Diabetes devices serve as highly effective instruments in diabetes management, providing both patients and healthcare providers with streamlined methods for monitoring blood glucose levels, administering insulin, and enhancing treatment effectiveness. A critical element of these devices efficiency is their capacity to deliver precise and prompt information on glucose levels. Technological progressions in these devices are anticipated to bolster market expansion. Notably, the development of continuous glucose monitoring (CGM) systems represents a significant advancement, furnishing real-time glucose readings around the clock, and eliminating the necessity for frequent fingerstick tests.
Furthermore, companies operating in the Saudi Arabia diabetes devices industry are working to improve their product offerings by upgrading their products, leveraging important cooperative drives, as well as considering acquisitions and government approvals these efforts are aimed at expanding their customer base and gaining a larger share of the market. For instance, in August 2023, Nemaura Medical received Saudi Food and Drug Authority (SFDA) approval for its sugarBEAT sensor, a non-invasive glucose sensor.
Saudi Arabia Diabetes Devices Market Report Highlights
- In 2023, the insulin delivery devices segment dominated the type segment by capturing a revenue share of 54.2%
- The insulin delivery devices segment is anticipated to grow at the fastest CAGR during the forecast period
- Based on distribution channel, hospital pharmacies segment held the largest market share of more than 50% in 2023
- Retail pharmacies segment is expected to grow at the fastest CAGR during the forecast period
- Among end-use, hospitals held a majority share of the market of 40.8% in 2023
- The diagnostic centers segment is expected to grow at the fastest rate over the forecast period
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Distribution Channel
1.2.3. End-use
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Distribution Channel outlook
2.2.3. End-use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
CHAPTER 3. SAUDI ARABIA DIABETES DEVICES MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Growing prevalence of diabetes
3.2.1.2. Technological Innovations & Product Advancements
3.2.1.3. Growing focus on diabetes care
3.2.2. Market restraint analysis
3.2.2.1. Stringent regulatory policies and regulations
3.2.2.2. High cost of devices
3.3. Saudi Arabia Diabetes Devices Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five forces
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
CHAPTER 4. SAUDI ARABIA DIABETES DEVICES MARKET: TYPE ESTIMATES & TREND ANALYSIS
4.1. Type Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Saudi Arabia Diabetes Devices Market by Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5. Blood Glucose Monitoring Devices
4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2. Self-Monitoring Devices
4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2.2. Blood Glucose Meters
4.5.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2.3. Testing Strips
4.5.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2.4. Lancets
4.5.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3. Continuous Glucose-Monitoring Devices
4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3.2. Sensors
4.5.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3.3. Transmitters
4.5.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3.4. Receiver
4.5.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Insulin Delivery Devices
4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6.2. Insulin Pumps
4.6.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6.3. Insulin Pens
4.6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6.4. Insulin Syringes
4.6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6.5. Insulin Jet injectors
4.6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. SAUDI ARABIA DIABETES DEVICES MARKET: DISTRIBUTION CHANNEL ESTIMATES & TREND ANALYSIS
5.1. Distribution Channel Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Suadi Arabia Diabetes Devices Market by Distribution Channel Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Hospital Pharmacies
5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Retail Pharmacies
5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Diabetes Clinics/Centers
5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.8. Online Pharmacies
5.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.9. Others
5.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. SAUDI ARABIA DIABETES DEVICES MARKET: END-USE ESTIMATES & TREND ANALYSIS
6.1. End-use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Saudi Arabia Diabetes Devices Market by End-use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5. Hospitals
6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Diagnostic Centers
6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Homecare
6.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Key Company Market Share Analysis, 2023
7.4. Company Position Analysis, 2023
7.5. Company Categorization (Emerging Players, Innovators, and Leaders)
7.6. Company Profiles
7.6.1. Medtronic plc
7.6.1.1. Company overview
7.6.1.2. Financial performance
7.6.1.3. Product benchmarking
7.6.1.4. Strategic initiatives
7.6.2. Abbott Laboratories
7.6.2.1. Company overview
7.6.2.2. Financial performance
7.6.2.3. Product benchmarking
7.6.2.4. Strategic initiatives
7.6.3. F.Hoffmann-La-Ltd.
7.6.3.1. Company overview
7.6.3.2. Financial performance
7.6.3.3. Product benchmarking
7.6.3.4. Strategic initiatives
7.6.4. Bayer AG
7.6.4.1. Company overview
7.6.4.2. Financial performance
7.6.4.3. Product benchmarking
7.6.4.4. Strategic initiatives
7.6.5. Lifescan, Inc.
7.6.5.1. Company overview
7.6.5.2. Financial performance
7.6.5.3. Product benchmarking
7.6.5.4. Strategic initiatives
7.6.6. B Braun Melsungen AG
7.6.6.1. Company overview
7.6.6.2. Financial performance
7.6.6.3. Product benchmarking
7.6.6.4. Strategic initiatives
7.6.7. Dexcom Inc.
7.6.7.1. Company overview
7.6.7.2. Financial performance
7.6.7.3. Product benchmarking
7.6.7.4. Strategic initiatives
7.6.8. Insulet Corporation
7.6.8.1. Company overview
7.6.8.2. Financial performance
7.6.8.3. Product benchmarking
7.6.8.4. Strategic initiatives
7.6.9. Sanofi
7.6.9.1. Company overview
7.6.9.2. Financial performance
7.6.9.3. Product benchmarking
7.6.9.4. Strategic initiatives
7.6.10. Novo Nordisk A/S
7.6.10.1. Company overview
7.6.10.2. Financial performance
7.6.10.3. Product benchmarking
7.6.10.4. Strategic initiatives
7.6.11. BD
7.6.11.1. Company overview
7.6.11.2. Financial performance
7.6.11.3. Product benchmarking
7.6.11.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Distribution Channel
1.2.3. End-use
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Distribution Channel outlook
2.2.3. End-use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
CHAPTER 3. SAUDI ARABIA DIABETES DEVICES MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Growing prevalence of diabetes
3.2.1.2. Technological Innovations & Product Advancements
3.2.1.3. Growing focus on diabetes care
3.2.2. Market restraint analysis
3.2.2.1. Stringent regulatory policies and regulations
3.2.2.2. High cost of devices
3.3. Saudi Arabia Diabetes Devices Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five forces
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
CHAPTER 4. SAUDI ARABIA DIABETES DEVICES MARKET: TYPE ESTIMATES & TREND ANALYSIS
4.1. Type Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Saudi Arabia Diabetes Devices Market by Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5. Blood Glucose Monitoring Devices
4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2. Self-Monitoring Devices
4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2.2. Blood Glucose Meters
4.5.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2.3. Testing Strips
4.5.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2.4. Lancets
4.5.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3. Continuous Glucose-Monitoring Devices
4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3.2. Sensors
4.5.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3.3. Transmitters
4.5.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3.4. Receiver
4.5.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Insulin Delivery Devices
4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6.2. Insulin Pumps
4.6.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6.3. Insulin Pens
4.6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6.4. Insulin Syringes
4.6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6.5. Insulin Jet injectors
4.6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. SAUDI ARABIA DIABETES DEVICES MARKET: DISTRIBUTION CHANNEL ESTIMATES & TREND ANALYSIS
5.1. Distribution Channel Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Suadi Arabia Diabetes Devices Market by Distribution Channel Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Hospital Pharmacies
5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Retail Pharmacies
5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Diabetes Clinics/Centers
5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.8. Online Pharmacies
5.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.9. Others
5.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. SAUDI ARABIA DIABETES DEVICES MARKET: END-USE ESTIMATES & TREND ANALYSIS
6.1. End-use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Saudi Arabia Diabetes Devices Market by End-use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5. Hospitals
6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Diagnostic Centers
6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Homecare
6.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Key Company Market Share Analysis, 2023
7.4. Company Position Analysis, 2023
7.5. Company Categorization (Emerging Players, Innovators, and Leaders)
7.6. Company Profiles
7.6.1. Medtronic plc
7.6.1.1. Company overview
7.6.1.2. Financial performance
7.6.1.3. Product benchmarking
7.6.1.4. Strategic initiatives
7.6.2. Abbott Laboratories
7.6.2.1. Company overview
7.6.2.2. Financial performance
7.6.2.3. Product benchmarking
7.6.2.4. Strategic initiatives
7.6.3. F.Hoffmann-La-Ltd.
7.6.3.1. Company overview
7.6.3.2. Financial performance
7.6.3.3. Product benchmarking
7.6.3.4. Strategic initiatives
7.6.4. Bayer AG
7.6.4.1. Company overview
7.6.4.2. Financial performance
7.6.4.3. Product benchmarking
7.6.4.4. Strategic initiatives
7.6.5. Lifescan, Inc.
7.6.5.1. Company overview
7.6.5.2. Financial performance
7.6.5.3. Product benchmarking
7.6.5.4. Strategic initiatives
7.6.6. B Braun Melsungen AG
7.6.6.1. Company overview
7.6.6.2. Financial performance
7.6.6.3. Product benchmarking
7.6.6.4. Strategic initiatives
7.6.7. Dexcom Inc.
7.6.7.1. Company overview
7.6.7.2. Financial performance
7.6.7.3. Product benchmarking
7.6.7.4. Strategic initiatives
7.6.8. Insulet Corporation
7.6.8.1. Company overview
7.6.8.2. Financial performance
7.6.8.3. Product benchmarking
7.6.8.4. Strategic initiatives
7.6.9. Sanofi
7.6.9.1. Company overview
7.6.9.2. Financial performance
7.6.9.3. Product benchmarking
7.6.9.4. Strategic initiatives
7.6.10. Novo Nordisk A/S
7.6.10.1. Company overview
7.6.10.2. Financial performance
7.6.10.3. Product benchmarking
7.6.10.4. Strategic initiatives
7.6.11. BD
7.6.11.1. Company overview
7.6.11.2. Financial performance
7.6.11.3. Product benchmarking
7.6.11.4. Strategic initiatives
LIST OF TABLES
Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 Saudi Arabia diabetes devices market, by type, 2018 - 2030 (USD Million)
Table 4 Saudi Arabia diabetes devices market, by end-use, 2018 - 2030 (USD Million)
Table 5 Saudi Arabia diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 Saudi Arabia diabetes devices market, by type, 2018 - 2030 (USD Million)
Table 4 Saudi Arabia diabetes devices market, by end-use, 2018 - 2030 (USD Million)
Table 5 Saudi Arabia diabetes devices market, by distribution channel, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Saudi Arabia diabetes devices market: Market outlook
Fig. 9 Saudi Arabia diabetes devices market competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Saudi Arabia diabetes devices market driver impact
Fig. 15 Saudi Arabia diabetes devices market restraint impact
Fig. 16 Saudi Arabia diabetes devices market: type movement analysis
Fig. 17 Saudi Arabia diabetes devices market: type outlook and key takeaways
Fig. 18 Blood glucose monitoring devices market estimates and forecast, 2018 - 2030
Fig. 19 Self-monitoring devices market estimates and forecast, 2018 - 2030
Fig. 20 Blood glucose meters market estimates and forecast, 2018 - 2030
Fig. 21 Testing strips market estimates and forecast, 2018 - 2030
Fig. 22 Lancets market estimates and forecast, 2018 - 2030
Fig. 23 Continuous glucose monitoring devices market estimates and forecast, 2018 - 2030
Fig. 24 Sensors market estimates and forecast, 2018 - 2030
Fig. 25 Transmitters market estimates and forecast, 2018 - 2030
Fig. 26 Receivers market estimates and forecast, 2018 - 2030
Fig. 27 Insulin delivery devices market estimates and forecast, 2018 - 2030
Fig. 28 Insulin pumps market estimates and forecast, 2018 - 2030
Fig. 29 Insulin pens market estimates and forecast, 2018 - 2030
Fig. 30 Insulin syringes market estimates and forecast, 2018 - 2030
Fig. 31 Insulin jet injectors market estimates and forecast, 2018 - 2030
Fig. 32 Saudi Arabia diabetes devices market: distribution channel movement analysis
Fig. 33 Saudi Arabia diabetes devices market: distribution channel outlook and key takeaways
Fig. 34 Hospital pharmacies market estimates and forecast, 2018 - 2030
Fig. 35 Retail pharmacies market estimates and forecast, 2018 - 2030
Fig. 36 Diabetes clinics/centers market estimates and forecast, 2018 - 2030
Fig. 37 Online pharmacies market estimates and forecast, 2018 - 2030
Fig. 38 Others market estimates and forecast, 2018 - 2030
Fig. 39 Saudi Arabia diabetes devices market: end-use movement analysis
Fig. 40 Saudi Arabia diabetes devices market: end-use outlook and key takeaways
Fig. 41 Hospitals market estimates and forecast, 2018 - 2030
Fig. 42 Diagnostic centers market estimates and forecast, 2018 - 2030
Fig. 43 Homecare market estimates and forecast, 2018 - 2030
Fig. 44 Participant categorization- Saudi Arabia diabetes devices market
Fig. 45 Market share of key market players- Saudi Arabia diabetes devices market
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Saudi Arabia diabetes devices market: Market outlook
Fig. 9 Saudi Arabia diabetes devices market competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Saudi Arabia diabetes devices market driver impact
Fig. 15 Saudi Arabia diabetes devices market restraint impact
Fig. 16 Saudi Arabia diabetes devices market: type movement analysis
Fig. 17 Saudi Arabia diabetes devices market: type outlook and key takeaways
Fig. 18 Blood glucose monitoring devices market estimates and forecast, 2018 - 2030
Fig. 19 Self-monitoring devices market estimates and forecast, 2018 - 2030
Fig. 20 Blood glucose meters market estimates and forecast, 2018 - 2030
Fig. 21 Testing strips market estimates and forecast, 2018 - 2030
Fig. 22 Lancets market estimates and forecast, 2018 - 2030
Fig. 23 Continuous glucose monitoring devices market estimates and forecast, 2018 - 2030
Fig. 24 Sensors market estimates and forecast, 2018 - 2030
Fig. 25 Transmitters market estimates and forecast, 2018 - 2030
Fig. 26 Receivers market estimates and forecast, 2018 - 2030
Fig. 27 Insulin delivery devices market estimates and forecast, 2018 - 2030
Fig. 28 Insulin pumps market estimates and forecast, 2018 - 2030
Fig. 29 Insulin pens market estimates and forecast, 2018 - 2030
Fig. 30 Insulin syringes market estimates and forecast, 2018 - 2030
Fig. 31 Insulin jet injectors market estimates and forecast, 2018 - 2030
Fig. 32 Saudi Arabia diabetes devices market: distribution channel movement analysis
Fig. 33 Saudi Arabia diabetes devices market: distribution channel outlook and key takeaways
Fig. 34 Hospital pharmacies market estimates and forecast, 2018 - 2030
Fig. 35 Retail pharmacies market estimates and forecast, 2018 - 2030
Fig. 36 Diabetes clinics/centers market estimates and forecast, 2018 - 2030
Fig. 37 Online pharmacies market estimates and forecast, 2018 - 2030
Fig. 38 Others market estimates and forecast, 2018 - 2030
Fig. 39 Saudi Arabia diabetes devices market: end-use movement analysis
Fig. 40 Saudi Arabia diabetes devices market: end-use outlook and key takeaways
Fig. 41 Hospitals market estimates and forecast, 2018 - 2030
Fig. 42 Diagnostic centers market estimates and forecast, 2018 - 2030
Fig. 43 Homecare market estimates and forecast, 2018 - 2030
Fig. 44 Participant categorization- Saudi Arabia diabetes devices market
Fig. 45 Market share of key market players- Saudi Arabia diabetes devices market
